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Introduction {#sec1}
============

Unlike mammals, vertebrates of piscine and amphibian groups possess very remarkable regenerative potential in almost all tissue types and organs and thus have been studied extensively for a greater understanding of the molecular mechanisms underlying tissue regeneration ([@bib1], [@bib11], [@bib13], [@bib26], [@bib35], [@bib39], [@bib42], [@bib51], [@bib53]). Zebrafish, a piscine member, is an excellent model to study the molecular mechanisms of regeneration in complex tissues like brain and retina. Retina regeneration in zebrafish depends mostly on the de-differentiation of Müller glia (MG), which then reprogram themselves to produce progenitor cells with stem cell-like properties (MG-derived progenitor cells \[MGPCs\]). Later, these MGPCs differentiate into various neurons of the retina and the MG itself with the help of different contributing factors ([@bib10], [@bib44]). These include growth factors ([@bib16], [@bib49], [@bib54], [@bib60]), cytokines ([@bib55], [@bib60]), gene transcription factors ([@bib38], [@bib43], [@bib47], [@bib52], [@bib55]), epigenome modifiers ([@bib40], [@bib41]), cell-cycle regulators ([@bib33], [@bib46], [@bib47]), and differentiation factors ([@bib37]), which get dynamically regulated with precise orchestration among themselves, leading to the restoration of normal vision ([@bib50]). Conversely, mammalian retina often undergoes reactive gliosis upon injury, which eventually leads to scar formation ([@bib5]). Although good knowledge of the molecular regulatory networks that form the foundation of regeneration cascade exist in zebrafish, several important gene regulatory networks remain enigmatic. One such unknown territory is the involvement of epigenome modifiers like histone deacetylases (Hdacs). Unraveling crucial gene regulatory network underlying retina regeneration, with temporal and spatial precision, would be possible only through an understanding of the epigenome modifiers such as Hdacs and the subsequent genes involved. Finally, we anticipate that the cellular and molecular regulatory mechanisms that bring about regeneration in the zebrafish could pave the way for curing mammalian retinal damage.

Hdacs usually function as catalysts for the deacetylation of acetyl-L-lysine side chains of histone proteins by forming transcriptional co-repressor complexes, which typically enable the alteration of chromatin structure and repress gene transcription. There are 4 major classes of Hdacs with diverse functions including the modifications of non-histone targets in normal cell biology ([@bib17]). Furthermore, HDAC inhibitors are of immense interest to the research and medical communities, which focus on tackling their anti-cancer properties to develop them as potential tools for cancer treatment ([@bib32], [@bib57]). Hdac1 knockout is embryonically lethal in mice and is known to cause cell proliferation defects through the upregulation of cyclin-dependent kinase inhibitors like p21 and p27 ([@bib27], [@bib36], [@bib57]). The decline in Hdac1 is also associated with a decrease in overall Hdac activity exhibited by other Hdacs, which is usually not complemented by overexpression of Hdac2 or Hdac3 ([@bib27], [@bib36], [@bib57]). These attributes along with its near-ubiquitous expression make Hdac1 unique, which demands further exploration in regeneration biology of the retina. Hdac1 being part of multi-protein nuclear complexes that are important for causing transcriptional repression and epigenetic landscaping to inhibit the expression of neuronal-specific genes in rest of the tissues ([@bib18]) made us explore the global gene regulations that occur in MGPCs mediated through Hdacs with a particular focus on Hdac1. Furthermore, MG reprogramming leading to induction of MGPCs, with little neuronal characteristics, during retina regeneration is associated with essential expression of pluripotency-inducing factors ([@bib15], [@bib43], [@bib48]), which could also be targets of epigenome modifiers like Hdacs.

Here we unravel the unique roles played by Hdacs in regulating the expression of various regeneration-associated essential genes like *mycb*, *ascl1a*, *lin28a*, *insm1a*, and *her4.1* during MG reprogramming and induction of MGPCs. We also show the global changes in gene expression with compromised Hdac function during regeneration, through a whole retina RNA sequencing (RNA-seq) analysis. Furthermore, we unravel a few novel gene regulatory networks that connect Hdacs with Delta-Notch signaling, *lin28a*, and a few essential cytokines. We also show the importance of Hdacs in regulating *her4.1* to restrict *lin28a* expression, which is a necessity for the translation of various genes like *ascl1a*, and *mycb* through the suppression of *let-7* microRNA. Our study, therefore, unravels the hitherto unknown facts about Hdacs to bring about the induction of MGPCs for successful retina regeneration.

Results {#sec2}
=======

Hdacs Are Necessary for MGPCs\' Induction after Retinal Injury {#sec2.1}
--------------------------------------------------------------

There are different methods to study regeneration, of which needle poke is quicker, more natural, and less traumatic to the fishes. In this method, we injure the retina of fish using a 30G needle after administering deep anesthesia and harvest the eye at various time points. Analysis of *hdac*s gene expression following retinal injury revealed that *hdac3*, *hdac5*, and *hdac6* get rapidly induced and *hdac1*, *hdac4*, *hdac7*, and *hdac9* get downregulated ([Figure 1](#fig1){ref-type="fig"}A). The mRNA *in situ* hybridization (ISH) analysis revealed a panretinal expression of *hdac1* in the uninjured retina, which declines drastically after an injury. Although the mRNA of *hdac1* reappeared near the injury spot at 4 days post-injury (dpi), interestingly, it showed exclusion from the majority of bromodeoxyuridine^+^ (BrdU^+^) cells and co-localized with only a fraction of progenitors ([Figures 1](#fig1){ref-type="fig"}B, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B). We saw a similar pattern of expression for *hdac3*, *hdac4*, *hdac5*, *hdac6,* and *hdac9* ([Figures S1](#mmc1){ref-type="supplementary-material"}C--S1L). The cell count data of *hdac1*-expressing cells showed an increased co-localization with proliferating cell nuclear antigen (PCNA) compared with the ones having just BrdU ([Figure S1](#mmc1){ref-type="supplementary-material"}B). PCNA, a molecule with a longer half-life and an ability to stay detectable even after cell-cycle exit ([@bib3], [@bib25], [@bib34]), could efficiently be used as an indicator of post-proliferative status as well. From our results, the increased co-localization of *hdac1* with PCNA compared with BrdU pulse-labeled cells suggests that *hdac1* gets upregulated in post-proliferative MGPCs. Interestingly, immunofluorescence showed a drastic decline in Hdac1 protein expression in MGPCs at 4 dpi ([Figure 1](#fig1){ref-type="fig"}C), but we found a higher percentage co-labeling with BrdU, at 2 and 6 dpi ([Figure S2](#mmc1){ref-type="supplementary-material"}A). However, no significant temporal variation was seen in Hdac1 protein levels at different time points post injury in the whole retinal extract ([Figure S2](#mmc1){ref-type="supplementary-material"}B).Figure 1Hdacs\' Inhibition Suppresses the Formation of MGPCs(A) qPCR assay shows injury-dependent regulation of *hdacs*. \*p \< 0.04, n.s, not significant.(B) ISH microscopy of *hdac1* expression in uninjured state and at various time points after retinal injury.(C) Immunofluorescence (IF) microscopy shows that Hdac1 expression is mostly absent from BrdU^+^ cells at the site of injury, in the retina at 4 dpi. Arrowheads indicate co-labeled Hdac1^+^ and BrdU^+^ cells, arrows mark Hdac1^−^ but BrdU^+^ cells.(D) qPCR assay of *hdac1* from GFP-positive and GFP-negative sorted cells from *1016tuba1a*: GFP transgenic retina at 4 dpi. ^∗^p\<0.002.(E and F) MO-based *hdac1* knockdown using two different MOs separately decreases BrdU^+^ cells, relative to the control MO (E), which accounts for 80% reduction in cell number (F) in 2 dpi retina; ANOVA test, \*p \< 0.001. MOs were delivered at the time of injury, electroporated immediately after injury, and harvested at 2 dpi.(G) *hdac1* inhibition using antisense MO (0.5 mM) causes upregulation of acetylated histone 4 compared with control (0.5 mM), revealed by IF microscopy in 4 dpi retina.N = 6 biological replicates in all experiments unless specified. Scale bars, 10 μm in (B, C, E, and G). Error bars are SD. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. The asterisk marks the injury site in (B, C, E, and G). See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

We further conducted experiments using transgenic fish that marks proliferating MGPCs in the retina. For this, a *1016tuba1a*: GFP transgenic zebrafish, which is well characterized to mark proliferating MG-derived progenitors after an injury ([@bib10]), was used. Furthermore, the *1016tuba1a*: *Cre-*ERT2/β-actin-LCLG double transgenic fish was used in previous studies to identify the lineage of the MG-derived progenitors in regenerating zebrafish retina ([@bib44], [@bib45]). Using this *1016tuba1a*: GFP transgenic zebrafish, we sorted the GFP-positive and GFP-negative cell populations from the injured retina to explore the levels of *hdac1* mRNA. Interestingly, we found significant downregulation of *hdac1* mRNA in the GFP-positive population, compared with the rest of the cells ([Figure 1](#fig1){ref-type="fig"}D), suggesting that GFP-positive MGPCs need to have a declined *hdac1* expression for a successful regenerative response of the retina. These observations indicate that Hdac1-mediated gene regulation is prevalent both in MGs that are yet to dedifferentiate and enter the cell cycle and in post-proliferative MGPCs.

To investigate the role of Hdac1 during regeneration, *hdac1*-targeting morpholino (MO), which blocked its protein expression, was used ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). The *hdac1*-targeting MOs were delivered separately and electroporated at the time of injury and harvested at 2 dpi, which resulted in 80% decline in the number of proliferating cells ([Figures 1](#fig1){ref-type="fig"}E, 1F, [S2](#mmc1){ref-type="supplementary-material"}E, and S2F). Transfection of *hdac1* and *gfp* reporter mRNA along with the respective MO that does not bind onto the delivered mRNA could rescue the reduction in cell proliferation in the retina at 2 dpi ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). We also found an enhanced proliferation with *gfp-hdac1* fusion mRNA transfection in these rescue experiments ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B).

We then decided to explore the specific effect of *hdac1* knockdown on cell proliferation in the early and late proliferative phases of regeneration. For this, we performed late *hdac1* knockdown experiments in which the retina is allowed to regenerate until 2 or 4 dpi and then electroporated with *hdac1* MO and harvested at 4 or 6 dpi, respectively ([Figures S3](#mmc1){ref-type="supplementary-material"}D--S3I). Although we delivered the MO during injury, it remains dormant in the vitreous until electroporated to get entry into the retina enabling *hdac1* knockdown. In both these sets, we found a decline in the MGPCs marked by PCNA compared with the control MO group, as observed in the 0--2 dpi *hdac1*-knockdown groups. MO-mediated *hdac1* repression also caused an upregulation of acetylated histone 4 (Ac.H4) in the retina, which demonstrated the efficacy of Hdac inhibition ([Figure 1](#fig1){ref-type="fig"}G). These findings suggest the existence of *hdac1*-mediated gene regulation in normal reprogramming and perpetuation of retina regeneration.

Furthermore, we explored the effect of the global decline in Hdac activity through well-characterized pharmacological inhibitors of Hdacs, valproic acid (VPA) and trichostatin A (TSA) separately ([@bib2], [@bib58]). We found that proliferation decreased up to 80% in VPA or TSA, and we reasoned that Hdacs could be associated with MGPCs induction in the retina, at 4 dpi ([Figures 2](#fig2){ref-type="fig"}A and 2B). The reduction in the number of MGPCs seen with VPA or TSA treatment was not because of apoptosis ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C) or DMSO in the drug as the solvent ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E). Furthermore, we observed increased levels of Ac.H4 by VPA and TSA treatment in the post-injured retina ([Figures 2](#fig2){ref-type="fig"}C, 2D, and [S4](#mmc1){ref-type="supplementary-material"}F). These results suggest the existence of Hdac-mediated gene regulatory pathway, which is necessary for the induction of retinal MGPCs during regeneration.Figure 2Hdacs and Her4.1 Mutually Inhibit Each Other during MGPCs-Mediated Retina Regeneration(A and B) Immunofluorescence (IF) microscopy on retinal sections shows a reduction in the number of proliferating MGPCs following Hdacs\' inhibition by VPA and TSA at 4 dpi (A), which is quantified in (B); ANOVA test, \*p \< 0.0001 in (B).(C and D) Western blot analysis revealed upregulated acetylated histone 4 with Hdacs inhibition at 2 dpi retina (C) and IF microscopy at 4 dpi (D), compared with uninjured and DMSO-treated control retina.(E) RT-PCR (upper) and qPCR (lower) of *her4.1* mRNA in DAPT-treated retina, compared with uninjured (UC) and 2 dpi retina. \*p \< 0.001.(F and G) RT-PCR (upper) and qPCR (lower) (F) and ISH and IF microscopies in 4 dpi retina (G) show that Hdac blocker VPA/TSA increases *her4.1* induction compared with respective controls. Arrowheads indicate co-labeled *her4.1*^+^ and BrdU^+^ cells, arrows mark *her4.1*^+^ but BrdU^−^ cells in (G). \*p \< 0.0001 in (F).(H) Single-cell-stage embryos were injected with *her4.1:luciferase* vector along with Renilla luciferase mRNA for normalization, which were then treated with TSA for 24 hr before lysing for quantification of *her4.1* promoter activity by dual luciferase assay. \*p \< 0.003.(I) Fluorescence *in situ* hybridization and IF microscopy show co-localization of *her4.1* and *hdac1* with BrdU^+^ MGPCs in 4 dpi retina. Arrowheads indicate *her4.1*^+^ and *hdac1*^−^ cells, arrows mark *her4.1*^−^ but *hdac1*^+^ cells.(J) qPCR of *hdac1, hdac4,* and *hdac9* mRNAs with blockade of Notch signaling by DAPT treatment, in 2 dpi retina; \*p \< 0.002.(K) Schematic experimental timelines for *her4.1* MO electroporation in the retina.(L) qPCR of *hdac1* in *the her4.1* knockdown retina as per the experimental timeline in (K); \*p \< 0.03.N = 4 biological replicates in all experiments. Scale bars, 10 μm in (A, D, and G) and 20 μm in (I). The asterisk marks the injury site in (A, D, G, and I). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. See also [Figures S2, S4](#mmc1){ref-type="supplementary-material"}, and [S6](#mmc1){ref-type="supplementary-material"}.

We also performed a whole-retina RNAseq analysis, to explore the changes in global gene expression that occur with the compromised activity of Hdacs. For this, we used total retina isolated from zebrafish of, uninjured (UC), 12 hours post injury (hpi), 4 dpi, and VPA-treated 4 dpi experimental groups. The VPA-mediated Hdacs\' inhibition revealed several transcription factors that are up- or downregulated when compared with 12 hpi and 4 dpi ([Table S2](#mmc2){ref-type="supplementary-material"}; [Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H) (GEO accession: [GSE98094](ncbi-geo:GSE98094){#intref0010}), including several regeneration-associated genes, namely, *ascl1a*, *mycb*, *lin28a*, *foxn4,* and *insm1a* ([@bib13], [@bib23], [@bib43], [@bib46], [@bib47]). We further evaluated the molecular mechanisms of regulation of a few of these genes with regard to normal and deregulated activity of Hdacs.

Hdacs-Her4.1 Interplay Governs MGPCs Proliferation {#sec2.2}
--------------------------------------------------

Next, we explored the possible reasons for the MGPCs induction to be diminished upon Hdacs\' suppression. One such candidate gene was a Delta-Notch effector gene *her4.1*. We chose *her4.1* mainly because of its negative regulation on retina regeneration. Forced expression of *notch intracellular domain* (*nicd*), which upregulates *her4.1*, is known to repress MGPCs induction completely, whereas pharmacological inhibition of γ-secretase through the drug DAPT (*N*-\[*N*-(3,5-difluorophenylacetyl)-L-alanyl\]-*S*-phenylglycine-*t*-butyl ester), which decreases *her4.1* levels, caused an enhancement of the zone of proliferation in injured retina ([@bib6], [@bib54]) ([Figures 2](#fig2){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}I).

Interestingly, with Hdacs\' inhibition, we found a dose-dependent increase in *her4.1* expression in RT-PCR, qPCR, and mRNA ISH in both VPA- and TSA-treated post-injured retina ([Figures 2](#fig2){ref-type="fig"}F and 2G). The blockade of Hdacs reflects a decline in BrdU pulse-labeled MGPCs with a concomitant increase in *her4.1* levels in the retina ([Figure 2](#fig2){ref-type="fig"}G). Furthermore, the injection of *her4.1:gfp-luciferase* reporter in zebrafish embryos exposed to TSA confirmed the *her4.1* gene upregulation by the inhibition of Hdacs ([Figure 2](#fig2){ref-type="fig"}H). Moreover, the VPA/TSA-treatment-associated increase in *her4.1* expression could be caused by the upregulation of *delta* and *notch* genes ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B), as discussed earlier ([Figures 2](#fig2){ref-type="fig"}F--2H).

We further explored if the increased *her4.1* levels seen in TSA-treated retina influenced the *hdac1* mRNA levels in the post-injured retina. We found an anticipated decline in *hdac1* mRNA levels revealed by mRNA ISH in TSA-treated 4 dpi retina ([Figure S5](#mmc1){ref-type="supplementary-material"}C). These results suggest the existence of Her4.1-mediated repression of *hdac1* expression. In another scenario, the Hdac1 protein levels also declined in the uninjured retina with VPA treatment in a dose-dependent manner ([Figure S5](#mmc1){ref-type="supplementary-material"}D).

Further analysis by double mRNA ISH of *hdac1* and *her4.1* showed their co-expression in a limited number of cells at 4 dpi ([Figure 2](#fig2){ref-type="fig"}I). We also found several *hdac1*-positive cells that are *her4.1* negative, and *vice versa*. Furthermore, the DAPT-mediated inhibition of Delta-Notch signaling, which brings down *her4.1* levels ([@bib6], [@bib54]) ([Figures 2](#fig2){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}I), caused an enhancement of *hdac1*, *hdac4,* and *hdac9* expression at 2 dpi ([Figure 2](#fig2){ref-type="fig"}J). It is interesting to note that *hdac1*, *hdac4*, and *hdac9* showed a similar temporal expression pattern post-retinal injury ([Figure 1](#fig1){ref-type="fig"}A). This observation supports the possibility that these three genes are regulated similarly. Furthermore, to confirm the influence of Her4.1 on *hdac1* expression, we employed MO-based gene knockdown approach. We analyzed the efficacy of *her4.1*-targeting MO in zebrafish embryos by co-injection with a construct harboring MO-binding sequence appended to GFP along with *her4.1* or control MO ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Similarly, we saw upregulation of *hdac1* expression with the *her4.1* knockdown from 0 to 4 dpi ([Figures 2](#fig2){ref-type="fig"}K and 2L). Notably, the *hdac1* expression from its earlier panretinal nature, immediately after the injury, stayed restricted to the neighboring cells of MGPCs. This type of *hdac1* expression could be a post-proliferative phenomenon seen from its increased co-labeling with PCNA ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Her4.1-mediated gene repression may be a potential cause for this. This speculation is also because of the increased *her4.1* expression in neighboring cells of actively proliferating MGPCs in the injured retina at 4 dpi ([Figures S5](#mmc1){ref-type="supplementary-material"}E and S5F). At later stages of regeneration, this type of Her4.1 expression probably necessitates the stringent regulation of Hdac1 expression in the neighboring cells of actively proliferating MGPCs. It is mainly evident from the decline in the *hdac1* levels in a *her4.1*-repressed scenario from 3 to 5 dpi ([Figures 2](#fig2){ref-type="fig"}K and 2L). It is also important to note that if *her4.1* is inhibited immediately after the retinal injury, we found an increase in *hdac1* expression ([Figure 2](#fig2){ref-type="fig"}L). These findings suggest that Her4.1 has a role in *hdac1* repression at early stages that is just opposite at later stages of regeneration. These results presumably indicate a mutual but differential regulation between Her4.1 and Hdac1 during various phases of regeneration.

*lin28a* Expression Mediated through Hdacs Is Necessary during Retina Regeneration {#sec2.3}
----------------------------------------------------------------------------------

Furthermore, we probed for the expression pattern of regeneration-associated genes like *mycb*, *ascl1a*, and *insm1a* in VPA/TSA-treated retina. Interestingly, we found an increase in the expression of genes *mycb* and *ascl1a*, and a sharp decline in *insm1a* levels, in the VPA-treated injured retina ([Figures 3](#fig3){ref-type="fig"}A--3D) and luciferase assay done in zebrafish embryos ([Figure 3](#fig3){ref-type="fig"}E). The decrease in *insm1a*, a transcriptional repressor ([@bib47]), also may contribute to enhanced *mycb* and *ascl1a* levels. The *ascl1a* and *mycb* were also regulated similarly with the *hdac1* knockdown in the retina ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C). Surprisingly, the increased mRNA levels of *ascl1a* and *mycb* seen in Hdac-inhibited retina did not show a corresponding increase in their protein levels, which instead decreased ([Figures 3](#fig3){ref-type="fig"}F--3H). We speculated that lack of Lin28a-mediated suppression of *let-7* microRNA could be the possible reason for reduced protein translation of Ascl1a and Myc from their mRNAs, as described earlier ([@bib43]). We found a significant reduction in *lin28a* expression in Hdacs-inhibited retina after injury ([Figures 3](#fig3){ref-type="fig"}I, 3J, [S6](#mmc1){ref-type="supplementary-material"}A, S6D, and S6E). Furthermore, the cell proliferation results in rescue experiments ([Figure S3](#mmc1){ref-type="supplementary-material"}A and S3B) may also be because of changes in *lin28a* mRNA levels ([Figure S3](#mmc1){ref-type="supplementary-material"}C). The reduction in *lin28a* levels caused an anticipated increase in the *let-7* microRNA in TSA/VPA-treated retina ([Figure 3](#fig3){ref-type="fig"}K). The abundant *let-7* microRNA could block the translation of regeneration-associated mRNA such as *ascl1a* and *mycb*, which justified the reduced protein levels of Ascl1a and Mycb ([Figures 3](#fig3){ref-type="fig"}F--3H).Figure 3Hdacs\' Repression Causes Upregulation of *ascl1a* and *mycb*, and Repression of *insm1a* and *lin28a*(A and B) RT-PCR (upper) and qPCR (lower) show upregulation of *mycb* (A) and *ascl1a* (B) with VPA-mediated Hdacs\' repression, relative to the control in 2 dpi retina; \*p \< 0.0001.(C) ISH microscopy reveals that *ascl1a* and *mycb* mRNAs show an expanded zone of expression at 4 dpi, with VPA.(D) RT-PCR (upper) and qPCR (lower) show downregulation of *insm1a* in Hdacs\' blockers TSA (left) and VPA (right) by qPCR, relative to the control in 2 dpi retina. \*p \< 0.003.(E) Hdacs\' repression using TSA inhibits luciferase activity in 24 hours post fertilization embryos injected with *insm1a:gfp-luciferase* vector; \*p \< 0.0002.(F and G) Western blot analysis reveals a decline in Ascl1a and Myc protein levels in 2 dpi retina treated with VPA (F) and TSA (G), compared with control. GS, glutamine synthetase; it is the loading control.(H) Densitometry analysis of western blots from (F), done in triplicates. \*p \< 0.003, n.s, not significant.(I and J) RT-PCR (upper) and qPCR (lower) show a decline in *lin28a* expression at 2 dpi retina (I), confirmed by ISH microscopy (J), with VPA-mediated Hdacs\' repression, compared with the control in 4 dpi retina; ANOVA test, \*p \< 0.0002 in (I). N = 3 biological replicates.(K) qPCR analysis of the *let-7a* microRNA shows an upregulation with VPA/TSA treatment in 4 dpi retina. \*p \< 0.001.(L) TSA-treated 3 dpa fin shows a reduction in blastema compared with DMSO control.(M) qPCR analysis of the VPA-treated fin blastema shows an increase in *her4.1* and decrease in *lin28a* mRNA levels at 6 dpa compared with control. \*p \< 0.002.Scale bars, 10 μm in (C and J) and 500 μm in (L). The asterisk marks the injury site in (C and J). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. See also [Figures S3--S6](#mmc1){ref-type="supplementary-material"}.

Interestingly, the regenerating caudal fin blastema also showed a decrease in cell mass in response to TSA-mediated Hdac inhibition ([Figure 3](#fig3){ref-type="fig"}L). Furthermore, we observed increased levels of Ac.H4 by VPA/TSA treatment in 6 days post amputation (dpa) fin blastema ([Figure S6](#mmc1){ref-type="supplementary-material"}F) as found in the post-injured retina ([Figures 2](#fig2){ref-type="fig"}C, 2D, and [S4](#mmc1){ref-type="supplementary-material"}F). Interestingly, Hdac inhibition-mediated decline in fin blastema also showed increased *her4.1* and decreased *lin28a* levels ([Figure 3](#fig3){ref-type="fig"}M), similar to that seen in the retina ([Figures 2](#fig2){ref-type="fig"}F and [3](#fig3){ref-type="fig"}I). These results suggest the existence of a possibly conserved Hdac-dependent gene regulatory pathway during the regeneration of various tissues.

Inhibition of Hdacs, the facilitators of transcriptional repression, caused a decline in the expression of genes like *lin28a*, which seemed a puzzle. However, our previous results suggested the existence of a potential transcriptional repressor such as Her4.1, which in TSA-treated retina stays upregulated ([Figures 2](#fig2){ref-type="fig"}F and 2G). This enhancement of *her4.1* could mediate the decline in the expression of *lin28a*.

Her4.1 Directly Represses the Expression of *lin28a* in Injured Retina {#sec2.4}
----------------------------------------------------------------------

Since we found an upregulation of *her4.1* and downregulation of *lin28a* in Hdacs-inhibited retina, we explored whether Her4.1 had any direct effect on the expression levels of *lin28a*. We first examined the impact of reduced *her4.1*, caused by DAPT treatment, on *lin28a* promoter activity in zebrafish embryos, injected with *lin28a:gfp-luciferase* construct. The luciferase assay showed an increased promoter activity in a dose-dependent manner ([Figure 4](#fig4){ref-type="fig"}A), which supported this view. To ascertain further the involvement of Her4.1 in *lin28a* expression, we examined its promoter for potential Her/Hes binding sites ([@bib22]) and found two putative binding sites ([Figure 4](#fig4){ref-type="fig"}B). At first, we validated if the *her4.1:gfp-luciferase* construct showed upregulation of promoter activity with *nicd* mRNA co-injected in zebrafish embryos. We found an expected upregulation of *her4.1* promoter activity in a dose-dependent manner ([Figure 4](#fig4){ref-type="fig"}C). We then co-injected zebrafish embryos with *lin28a:gfp-luciferase* reporter bearing either wild-type or mutated Her/Hes binding sites on *lin28a* promoter separately, along with increasing concentrations of *nicd* mRNA. We found that NICD overexpression caused a dose-dependent downregulation of *lin28a* promoter activity in the wild-type construct, which was absent in the mutant. These results showed that Her/Hes binding onto *lin28a* promoter negatively contributes to its functionality ([Figure 4](#fig4){ref-type="fig"}D). Fluorescence ISH analysis revealed that many *her4.1*-expressing cells showed weak *lin28a* levels, and *vice versa* ([Figure 4](#fig4){ref-type="fig"}E). This observation also suggested the existence of a Her4.1-mediated *lin28a* repression in retinal MGPCs. Furthermore, the knockdown of *her4.1* during the active proliferative phase of regeneration also confirmed these results. We found that blockade of *her4.1* from 3 to 5dpi caused an increase in *lin28a* levels in the retina ([Figures 4](#fig4){ref-type="fig"}F and 4G). Furthermore, the late knockdown of *her4.1* also caused a significant increase in the BrdU^+^ MGPCs in the retina ([Figures 4](#fig4){ref-type="fig"}H--4J), probably because of increased *lin28a* expression as demonstrated before ([@bib9], [@bib43]). These results supported the earlier conjecture that Hdacs upregulated the expression of *lin28a* through downregulation of a repressor like Her4.1.Figure 4Her4.1 Restricts the Zone of MGPCs by Suppressing *lin28a* Expression(A) Notch inhibition by DAPT stimulates luciferase activity in 24 hours post fertilization (hpf) embryos injected with *lin28a:gfp-luciferase* vector. \*p \< 0.0001.(B) Diagram of *lin28a* promoter with putative Her/Hes binding sites.(C) NICD overexpression stimulates luciferase activity in 24 hpf embryos injected with *her4.1:gfp-luciferase* vector compared with control. \*p \< 0.0002.(D) NICD regulates *lin28a* promoter-driven reporter activity in zebrafish embryos, co-injected with *lin28a:gfp-luciferase* construct and *nicd* mRNA, through the Her/Hes binding sites on the *lin28a* promoter, relative to 0 ng *nicd* mRNA; \*p \< 0.005; n.s, not significant.(E) Fluorescence *in situ* hybridization microscopy shows mutual exclusion of *her4.1* and *lin28a*, and IF marks BrdU^+^ MGPCs in 4 dpi retina. Arrowheads indicate co-labeled *her4.1*^+^ and *lin28a*^+^ cells, arrows indicate *her4.1*^+^ but *lin28a*^−^ cells.(F) Schematic of experimental timelines for *her4.1* MO electroporation.(G) qPCR of *lin28a* in *her4.1* knockdown retina as per experimental timeline in (F). ^∗^p\<0.001.(H--J) Experimental timelines for *her4.1* MO electroporation (H); immunofluorescence microscopy shows increased number of BrdU^+^ cells in retinal sections electroporated with lissamine-tagged *her4.1* MO as per H (I); quantification of BrdU^+^ cells seen with late knockdown of *her4.1* in (I) (J); \*p \< 0.0002 in (J).N = 3 biological replicates in all experiments. Scale bars, 10 μm in (E and I). The asterisk marks the injury site in (E and I). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. See also [Figures S2--S6](#mmc1){ref-type="supplementary-material"}.

Hdac Inhibition Reversibly Suppresses MGPCs\' Formation and Differentiation {#sec2.5}
---------------------------------------------------------------------------

We further investigated whether inhibition of Hdacs had a long-lasting impact on retina regeneration. To address this, we performed two sets of experiments. In the first one, fish were dipped in VPA from the time of injury until 4 dpi, immediately an intraperitoneal injection of BrdU was administered, and the eyes were harvested at 8 dpi ([Figure 5](#fig5){ref-type="fig"}A). In the second set, we performed the same experiment, except that the BrdU pulsing was given at 8 dpi and eyes were harvested after 5 hr ([Figure 5](#fig5){ref-type="fig"}D). These experiments were intended to demarcate the difference in performance of MGPCs with Hdacs\' inhibition and after its withdrawal. In the first set, we found a decline in BrdU^+^ cells at 8 dpi as a result of reduced proliferation at 4 dpi with VPA treatment. Interestingly, we found a significant increase in PCNA-positive cells in 8 dpi as opposed to control ([Figures 5](#fig5){ref-type="fig"}B and 5C). In the second set, we found a significant increase in BrdU^+^ cells, which mostly co-labeled with PCNA^+^ cells at 8 dpi ([Figures 5](#fig5){ref-type="fig"}E and 5F). These observations support the view that in the absence of Hdacs\' inhibition the BrdU^+^ cells seen at 8 dpi are newly formed MGPCs.Figure 5Hdacs\' Inhibition Reversibly Suppress MGPCs\' Formation and Differentiation(A--C) An experimental timeline showing VPA treatment from 0 to 4 dpi, BrdU pulse on 4 dpi, and harvest on 8 dpi (A), which shows the re-induction of PCNA^+^ and minimal BrdU^+^ proliferating cells revealed by immunofluorescence (IF) microscopy, compared with control (B), quantified in (C); ANOVA test, \*p \< 0.01 in (C).(D--F) An experimental timeline showing VPA treatment from 0 to 4 dpi and a BrdU pulse done on 8 dpi (D) shows co-labeling of BrdU^+^ and PCNA^+^ cells in the re-induced MGPCs in VPA-treated retina and minimal proliferating cells in control, which is revealed by IF microscopy (E), which is quantified in (F); ANOVA test, \*p \< 0.01 in (F).(G--J) The temporal evaluation of re-induced MGPCs, which are labeled with BrdU in an experiment timeline (G), which reveals that the regeneration occurs similar to control, revealed by IF microscopy (H), and cell quantification indicated its similarity to control in 9 and 60 dpi (I), with a preferential localization bias toward ONL than INL and GCL in VPA experimental regime compared with control (J); ANOVA test, \*p \< 0.01, \*\*p \< 0.02 in (J).N = 6 biological replicates in all experiments. Scale bars, 10 μm in (B, E, and H). Error bars are SD. The asterisk marks the injury site in (B, E, and H). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. See also [Figures S1--S4](#mmc1){ref-type="supplementary-material"}.

We further investigated, whether these newly formed MGPCs restore their functionality at a later stage of regeneration. For this, we labeled the newly formed MGPCs, after VPA withdrawal, with BrdU for 3 days. These BrdU cells were then traced up to 60 dpi and compared with those at 9 dpi in another similar experiment. The 9 dpi data would give us an idea about the approximate number of BrdU-positive cells that appeared in the retina after VPA withdrawal, which we then compared with the 60 dpi data. We found that the MGPCs migrated to various cell layers of the retina even at 60 dpi and showed only a marginal decline in cell number when compared with control, where there was no drug treatment ([Figures 5](#fig5){ref-type="fig"}G--5J).

Hdac-Her4.1 Axis Is Necessary for the Essential Cytokine Regulation during MGPCs Formation {#sec2.6}
------------------------------------------------------------------------------------------

Cytokines released at the site of injury trigger the regeneration cascade in the retina ([@bib8], [@bib16], [@bib55], [@bib60]). We reasoned that the reintroduction of MGPCs after TSA/VPA withdrawal might involve the active participation of cytokines, as Hdacs could regulate them in other systems ([@bib28], [@bib29], [@bib31]). To decipher this, we first examined if regeneration-associated cytokines are affected by TSA/VPA treatment. We found that the majority of the cytokines like *il6*, *il11a*, *il11b*, *lepa*, *lepb*, and *crlf* and receptors like *il11ra*, *lepr*, and *lifra* were significantly inhibited in 2 dpi retina treated with TSA/VPA ([Figures 6](#fig6){ref-type="fig"}A and 6B), which may also explain the lack of enough MGPCs for regeneration. Moreover, these cytokines, which get upregulated in the injured retina, were downregulated with Hdacs\' inhibition, revealed in a whole-retina RNA-seq analysis, at 4 dpi ([Figure S6](#mmc1){ref-type="supplementary-material"}G and [Table S1](#mmc1){ref-type="supplementary-material"}). We then investigated whether these cytokines possibly contribute to the reappearance of MGPCs and normal regeneration after withdrawal of Hdacs\' inhibition. To address this, we designed an experimental timeline in which zebrafish were given TSA dip treatment from the time of injury till 4 dpi and shifted to fresh water for 2 more days and the eyes harvested at 6 dpi ([Figure 6](#fig6){ref-type="fig"}C). The cytokines showed a drastic increase, more than the normal levels found in 2 or 6 dpi retina ([Figures 6](#fig6){ref-type="fig"}D and 6E). We speculated whether the increased *her4.1* levels caused by TSA/VPA treatment contributed to the decline in the levels of cytokines, as a potential reason for reduced proliferation after retinal injury. *In silico* analysis revealed several Hes/Her binding sites ([@bib22]) in the regulatory sequences of various cytokines addressed in this study ([Figure S6](#mmc1){ref-type="supplementary-material"}H). We then decided to probe if this Her4.1-mediated repression exists on cytokine gene regulations in injured retina. We performed knockdown of *her4.1* at 3 dpi and analyzed the levels of cytokines at 5 dpi ([Figure 6](#fig6){ref-type="fig"}F). Interestingly, we found upregulation of almost all cytokines with the *her4.1* knockdown in the retina ([Figure 6](#fig6){ref-type="fig"}G). We reasoned that the Her4.1-mediated repression of cytokines could get relieved with TSA withdrawal. In a confirmative result, we found that the enhanced levels of *her4.1* with TSA/VPA treatment would decline progressively after the drug withdrawal ([Figure 6](#fig6){ref-type="fig"}H). This observation could be because of auto--negative feedback regulation of Her4.1 on its transcription ([Figure 6](#fig6){ref-type="fig"}I) ([@bib56]), similar to other Hes/Her proteins\' auto-inhibitory regulations ([@bib12], [@bib19]). These results suggest that new injury is not necessary for the observed cytokine re-induction, as long as Her4.1 expression stays low after drug withdrawal. Furthermore, many regeneration-associated genes like *ascl1a*, *lin28a*, *mycb*, and *sox2* reappeared, probably influenced by the cytokines\' surge ([Figures 6](#fig6){ref-type="fig"}J--6L), causing an overall standard regenerative response.Figure 6Hdac-Influenced MGPCs\' Formation Is Mediated through Her4.1 Cytokine Axis(A and B) RT-PCR (A) and qPCR (B) assay revealed injury-induced expression of cytokines in uninjured, 2 dpi, and TSA-treated 2 dpi retina; \*p \< 0.01 in (B), N = 6 biological replicates.(C--E) Enhanced expression of cytokines in TSA withdrawal experiments as per the experimental timeline (C), shown by RT-PCR (D) and qPCR (E).(F) Experimental timelines for late knockdown of *her4.1*, from 3--5 dpi.(G) qPCR of various cytokines with 2 concentrations of *her4.1* MO electroporated as per experimental timeline in (F). ^∗^p\<0.001.(H) Downregulation of *her4.1* in TSA withdrawal experiments as per experimental timeline in (C); \*p \< 0.007.(I) qPCR of *her4.1* with two concentrations of *her4.1* MO electroporated as per experimental timeline in (F); \*p \< 0.004.(J--L) RT-PCR (J) and qPCR (K and L) were used to assay re-induction of injury-induced genes like *mycb*, *ascl1a*, *lin28a*, and *sox2* in uninjured, 2 dpi, and post-TSA treatment, which show significant upregulation of *lin28a* (K) and moderate increase in the level of other genes (L); ANOVA test, \*p \< 0.001 in (K).N = 6 biological replicates in all. Error bars are SD. See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"}.

Hdacs Are Necessary for Normal Distribution of MGPCs Across Retina Layers {#sec2.7}
-------------------------------------------------------------------------

As we found the necessity of Hdacs in MGPCs formation, a similar mechanism presumably underlies progenitor differentiation and their migration. We then explored if Hdacs are necessary for the movement of MGPCs across various retinal layers. In an experiment, we labeled almost all MGPCs with BrdU from the time of injury to 5 dpi ([Figure 7](#fig7){ref-type="fig"}A). The fish were then exposed to VPA from 7 to 14 dpi, with an aim to block Hdacs during the cell migration/differentiation phase of retina regeneration. Although we found no apparent reduction in the total number of cells at 14 dpi, there was a preferential localization of the migrated cells to the outer nuclear layer, with a marginal decrease in the inner nuclear layer and a significant decline in the ganglion cell layer ([Figures 7](#fig7){ref-type="fig"}B and 7C). These findings suggest that Hdacs-driven gene regulation persists even at later phases of retina regeneration, which could influence the migration pattern of MGPCs to various retinal layers.Figure 7Hdacs\' Inhibition Causes Selective Bias in MGPCs\' Migration toward the Outer Nuclear Layer(A--C) Determination of the fate of MGPCs in Hdac-inhibited condition as shown in experimental timeline (A), shows a significant increase of cell localization in ONL and a decline in INL and GCL, revealed by immunofluorescence (IF) microscopy (B) and quantified in (C), in the 14 dpi retina. \*p \< 0.0004 in (C), N = 6 biological replicates.(D) Signaling pathways and genes that are regulated by Hdacs at different times and stages of retina regeneration.Scale bar, 10 μm in (B). Error bars are SD. The asterisk marks the injury site in (B). ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

We explored the significance of HDACs, with a distinct focus on Hdac1, during retina regeneration and fin blastema formation in this study. Although the involvement of Hdac1 in progenitor differentiation is known during embryonic retinal development ([@bib59]), proper cell division, and maintenance of pluripotency of embryonic stem (ES) cells ([@bib20]), its mechanistic involvement during retina regeneration remained underexplored. Following injury, we found a drastic decline in the transcript levels of *hdac1* throughout the retina, which was restored back near MGPCs only at around 4 dpi. On the other hand, the protein level of Hdac1 remained unchanged in MGPCs and their neighboring cells until 4 dpi, a time when it stayed low in expression in MGPCs. Interestingly, at a later time point, 6 dpi, Hdac1 protein again become ubiquitous in all retinal cells. These seemingly contradictory observations regarding transcript and protein levels of Hdac1, found in our study, might hold the key to successful retina regeneration. The presence of Hdac1 protein in all retinal cells except MGPCs suggests the existence of Hdac1-mediated repression of regeneration-associated genes in these cells. Conversely, depletion of Hdac1 from MGPCs during proliferative phase ensures the reversal of this blockade of transcription as a necessity for successful proliferation. The reappearance of Hdac1 and the subsequent inhibition of transcription of regeneration-associated genes in post-proliferated MGPCs suggest its role not only in potentiating MGPCs for successful cell multiplication brought about by its depletion but also in controlling the extent of proliferation at the vicinity of injury. In an analogous situation, HDAC1 in ES cells was reported to selectively target the promoters of pluripotency-inducing factors like Oct4, Sox2, and Nanog as a requirement for controlling their expression ([@bib24]). Also, depletion of HDAC1 has been shown to cause enrichment of ES cell-specific gene expression. Similar necessary role of HDAC1 is also required for proper differentiation regime of ES cells ([@bib7]). Given the similarity between ES cells and MGPCs regarding gene expression, we speculate that the relocation of *hdac1* from its panretinal appearance to the neighboring cells of MGPCs probably would act similarly. Further studies are necessary to prove the guiding factors that regulate *hdac1* expression near MGPCs, and to find the collaborating factors that guide Hdac1 or other Hdacs to specific gene targets to regulate their expression.

Our study also supports another recently discovered phenomenon in mice retina, where the researchers over-expressed Ascl1 along with Hdac inhibition for promoting the regenerative capacity of mouse MG ([@bib21]). It is interesting to note that in our zebrafish study too we find a global decline in *hdac1*, *hdac4*, *hdac7,* and *hdac9* mRNA levels soon after injury. Furthermore, the mRNA levels are restored back to normalcy, but actively proliferating MGPCs lacked Hdac1 protein, which indicates that its absence is a favorable criterion for normal cell proliferation. However, the panretinal decline in Hdac activity was not a facilitator of MGPCs proliferation in zebrafish, probably because of upregulated Her4.1 and downregulated *lin28a* levels.

We found that the global decline in expression of other *hdac* genes, namely, *hdac4*, *hdac7*, and *hdac9,* in post-injured retina are restored back to normalcy at later stages of regeneration. This phenomenon may potentially act as a prelude to unblock the transcriptional repression of various pro-proliferative genes like pluripotency-inducing factors to bring about successful regeneration. Since we found a good correlation between the effects of *hdac1* knockdown and pan-Hdacs inhibition using TSA/VPA in regenerating retina, we speculate that Hdac1 might be capable of subduing the activity of other Hdacs, similar to that reported in other systems ([@bib27], [@bib36], [@bib57]). Increase in the level of acetylated histone4 upon knocking down *hdac1* separately or inhibiting all Hdacs through TSA also could justify the overall increase in gene expression of regeneration-associated genes like *ascl1a*, *myca*, *mycb*, and *her4.1*. We further show that the abundance of *her4.1* could account for reduced MGPCs, as is evident from its knockdown in the proliferative phase of regeneration, causing a significant increase in the number of MGPCs.

It is believed that Delta-Notch signaling enables the retina to limit the zone of proliferation near the injury site. Now, considering that *hdac1* expression is predominant in the post-proliferative phase of MGPCs, it is logical to find upregulated expression of *hdac*s upon *her4.1* blockade. In other words, decline in *her4.1* because of DAPT treatment, causing an increased cell number, could bring about more cells that exit cell cycle, and hence would accompany an increased *hdacs* level.

It is interesting to note that, upon knocking down *hdac1* separately or inhibiting all Hdacs in general, the number of MGPCs decline drastically with a deleterious effect on retina regeneration. This scenario might be possible through a super-abundance of a repressor like *her4.1*, which we found had a substantial inhibitory effect on *lin28a*, which is a vital pluripotency-inducing factor. According to a previous study ([@bib43]), a decrease in Lin28a would ensure the presence of high levels of *let-7* microRNA, which could prevent the translation of several regeneration-associated genes such as *ascl1a*, *mycb*, and *zic2b* and components of Sonic hedgehog signaling ([@bib23], [@bib43]). In support of this speculation, this study found that the panretinal Hdacs inhibition brought about an enhancement of *let-7* microRNA. Therefore, downregulation of *lin28a* and upregulation of *let-7* microRNA in the Hdacs-inhibited retina could repress the translation of *ascl1a* and *mycb*, despite their increased levels of mRNA, resulting in lack of adequate MGPCs formation. This part of the study also provides insights into the significance of depletion of Hdac1 in MGPCs, which in turn would regulate Her4.1 to induce Lin28a, which would be crucial for the successful proliferation of MGPCs.

Cytokine surge near the injury site often facilitates retinal regeneration ([@bib13], [@bib53]). The involvement of cytokines is also prominent in other tissue regeneration ([@bib4], [@bib14], [@bib30]), which makes the involvement of Hdacs-cytokines link crucial in retina-regeneration-specific gene expression paradigm. In general, the typical Hdacs expression necessitates the injury-induced cytokines as a prelude to successful regeneration, and their inhibition downregulates different regeneration-associated cytokines, thus culminating in reduced MGPCs proliferation. Withdrawal of the block on Hdacs function showed that the suspension of MGPCs proliferation by Hdacs inhibition was reversible, resulting in resumption of regeneration through a reappearance of cytokine surge and pluripotency factors like *lin28a*, which possibly is brought about by the disappearance of the abundant repressors like *her4.1*. This regulatory network could lead to the re-induction of MGPCs, which are BrdU-traceable even after 60 days.

The complex mechanism of temporal regulation of retina regeneration through Hdacs is presented in a model comprising the findings from this study ([Figure 7](#fig7){ref-type="fig"}D). In differentiated MG, the presence of Hdacs ensures blockade of transcription of pro-proliferative genes like *ascl1a* and *mycb*. The reported retinal abundance of *let-7* microRNA, which could block the translation of *ascl1a* and *mycb* also support this hypothesis ([@bib43]). Upon injury, through different cellular signaling pathways, pro-proliferative genes like *ascl1a* are highly induced, which upregulates *lin28a,* which helps in degradation of *let-7* microRNA. Therefore, in de-differentiating MGs, even though Hdacs might be present, gene regulatory networks responsible for differentiation are already afoot ensuring the successful formation of MGPCs. At this stage, Delta/Notch-signaling-mediated induction of *her4.1* in the neighboring cells of MGPCs could be responsible for inhibiting *lin28a* transcription, thus controlling the extension of de-differentiation and proliferation. In this study, the *her4.1* knockdown in the proliferative phase of regeneration causes an increase in the MGPCs. In proliferating MGPCs, depletion of Her4.1 is also necessary for building up adequate levels of *lin28a* and cytokines. Furthermore, to control the extent of regeneration, Her4.1, which is a downstream target of Notch signaling, self-downregulates its expression ([@bib56]), thus allowing reappearance of Hdacs, which may bring about differentiation of newly generated cells. Finally, our study unravels essential mechanisms by which Hdacs orchestrate these effects through mutual signaling pathways yielded through a tight regulation of Her4.1-Lin28a axis bringing changes in the expression of several regeneration-associated genes and cytokines. This study places Hdacs among critical regulators required for tissue regeneration, providing valuable insights for understanding signaling mechanisms that might help in understanding MG reprogramming in the injured mammalian retina, and also regarding damaged human retinae toward successful repair.

Limitation of the Study {#sec3.1}
-----------------------

Absence of a well-characterized Her4.1 antibody for use in zebrafish limited a few experimental explorations in this study.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods, Figures S1--S6, and Table S1Table S2. The List of Transcription Factors Regulated in Normal and VPA-Treated Retina, Related to Figures 1--3, 6, S4, and S6The table shows a list of transcription factors, transcription co-factors, and chromatin remodeling factors along with their ENSEMBL IDs, obtained from RNA-seq data that are regulated during various time points, and Hdac inhibition with VPA (valproic acid), post-retinal injury.Table S3. List of Primers Used in the Study, Related to Figures 1--4, 6, S3, S5, and S6All the primers used in this study are listed along with their names indicating the genes in first column and the 5′ to 3′ nucleotide sequence, in the next column.
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